Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 826-850 of 917 matching filings.

Per page
25
Current page
34
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Nov 2010
Reporting date
17 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
15 Nov 2010
Reporting date
15 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-31326

10-Q filing

Filing date
15 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-170140

EFFECT filing

Filing date
09 Nov 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
02 Nov 2010
Reporting date
29 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-170140

S-3 filing

Filing date
26 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-31326

10-K/A filing

Filing date
25 Oct 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
13 Oct 2010
Reporting date
06 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
30 Sep 2010
Reporting date
29 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-31326

10-K filing

Filing date
28 Sep 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-166277

424B3 filing

Filing date
24 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-166277

EFFECT filing

Filing date
23 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .